Stay updated on IMRT & Nivolumab for Recurrent Head & Neck Cancer Clinical Trial
Sign up to get notified when there's something new on the IMRT & Nivolumab for Recurrent Head & Neck Cancer Clinical Trial page.

Latest updates to the IMRT & Nivolumab for Recurrent Head & Neck Cancer Clinical Trial page
- Check4 days agoChange DetectedRevision: v3.3.4 was added and v3.3.3 was removed, reflecting a minor site version update. This update does not affect study details or results; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedLocations section updated to include Georgia, Ohio, and Wisconsin. HHS Vulnerability Disclosure and related location headings were removed; the page revision now shows v3.3.3.SummaryDifference0.4%

- Check48 days agoChange DetectedRevision: v3.3.2 updated from v3.3.1 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check55 days agoChange DetectedThe Publications section note updated to indicate PubMed auto-fill and potential irrelevance of listed publications to the study, and the revision tag changed to v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check62 days agoChange DetectedThe page no longer displays the funding-status notice about lapses in government funding and related operating guidance. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check76 days agoChange DetectedThe screenshots indicate no significant alterations to core content; only minor formatting or layout changes are visible. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to IMRT & Nivolumab for Recurrent Head & Neck Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMRT & Nivolumab for Recurrent Head & Neck Cancer Clinical Trial page.